跳至主要内容
临床试验/NCT02566291
NCT02566291已完成不适用

Supraglottic Airways LMA Supreme and Ambu AuraGain in Clinical Practice: a Prospective Observational Study

Johannes Gutenberg University Mainz1 个研究点 分布在 1 个国家目标入组 364 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
364
试验地点
1
主要终点
Success rate

研究概览

简要总结

In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.

详细描述

After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 Years
  • No concurrent participation in another study
  • capacity to consent
  • Present written informed consent of the research participant
  • Elective surgery under general anesthesia

排除标准

  • Age <18 years
  • Existing pregnancy
  • Lack of consent
  • inability to consent
  • emergency patients
  • Emergency situations in the context of a Difficult Airway Management
  • ASA classification> 3
  • situations where the possibility of accumulated gastric contents
  • Participation in another study

结局指标

主要结局

Success rate

时间窗: 70-98 Percent

overall and first attempt success rate

次要结局

  • Time for insertion(5-120 seconds)
  • Leakage in ml.min(0-300 ml.min)

研究者

发起方
Johannes Gutenberg University Mainz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marc Kriege, MD

Marc Kriege, MD; Rüdiger Noppens, MD

Johannes Gutenberg University Mainz

研究点 (1)

Loading locations...

相似试验